Lucid Diagnostics Financial Overview
Lucid Diagnostics's market cap is currently $144.57M. The company's EPS TTM is $-0.1; its P/E ratio is ―; Lucid Diagnostics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.
